CAMBRIDGE, Mass., June 22, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (NRBO) (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, ...
Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results